AstraZeneca Given Hold Rating at Deutsche Bank

Home › AstraZeneca Given Hold Rating at Deutsche Bank

's stock had its "hold" rating restated by equities researchers at Deutsche Bank in a report issued on Thursday, Analyst Ratings Network.com reports.

08.11	Trump tariffs could cost UK 22bn of exports
08.11	Watchdog to review police handling of Al Fayed abuse claims
08.11	Cattle marketing: Its about making the right decisions
08.11	Atlantic Tropical Weather Outlook
08.11	Eastern North Pacific Tropical Weather Outlook
08.11	Statement from the U.S. Green Building Council on the 2024 Election Results
08.11	Bolt drivers win right to holiday and minimum wage
08.11	INX details acquisition, SpectraGraphics grows and more
More »

je.st